European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.

Conservative management Diagnostics European Association of Urology guidelines Female lower urinary tract symptoms Mixed urinary incontinence Overactive bladder Pharmacological management Stress urinary incontinence Surgical management Urinary incontinence

Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
07 2022
Historique:
received: 16 01 2022
accepted: 26 01 2022
pubmed: 27 2 2022
medline: 15 6 2022
entrez: 26 2 2022
Statut: ppublish

Résumé

Female lower urinary tract symptoms (LUTS) are a common presentation in urological practice. Thus far, only a limited number of female LUTS conditions have been included in the European Association of Urology (EAU) guidelines compendium. The new non-neurogenic female LUTS guideline expands the remit to include these symptoms and conditions. To summarise the diagnostic section of the non-neurogenic female LUTS guideline and the management of female overactive bladder (OAB), stress urinary incontinence (SUI), and mixed urinary incontinence (MUI). New literature searches were carried out in September 2021 and evidence synthesis was conducted using the modified GRADE criteria as outlined for all EAU guidelines. A new systematic review (SR) on OAB was carried out by the panel for the purposes of this guideline. The important considerations for informing guideline recommendations are presented, along with a summary of all the guideline recommendations. Non-neurogenic female LUTS are an important cause of urological dysfunction. Initial evaluation, diagnosis, and management should be carried out in a structured and logical fashion based on the best available evidence. This guideline serves to present this evidence to health care providers in an easily accessible and digestible format. This report summarises the main recommendations from the European Association of Urology guideline on symptoms and diseases of the female lower urinary tract (bladder and urethra) not associated with neurological disease. We cover recommendations related to diagnosis of these conditions, as well as the treatment of overactive bladder, stress urinary incontinence, and mixed urinary incontinence.

Identifiants

pubmed: 35216856
pii: S0302-2838(22)01603-7
doi: 10.1016/j.eururo.2022.01.045
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-59

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 European Association of Urology. All rights reserved.

Auteurs

Arjun K Nambiar (AK)

Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK. Electronic address: arjunknambiar@gmail.com.

Salvador Arlandis (S)

Urology Department, La Fe University and Polytechnic Hospital, Valencia, Spain.

Kari Bø (K)

Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway.

Hanny Cobussen-Boekhorst (H)

Department of Urology, Radboud UMC, Nijmegen, The Netherlands.

Elisabetta Costantini (E)

Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Monica de Heide (M)

Bekkenbodem4All, Tiel, The Netherlands.

Fawzy Farag (F)

Department of Urology, Sohag University Hospital, Sohag, Egypt; Department of Urology, East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK.

Jan Groen (J)

Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands.

Markos Karavitakis (M)

Department of Urology, Charing Cross Hospital, London, UK.

Marie Carmela Lapitan (MC)

College of Medicine, Philippine General Hospital, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.

Margarida Manso (M)

Department of Urology, Centro Hospitalar Universitário São João, Porto, Portugal.

Serenella Monagas Arteaga (SM)

Department of Urology, University Hospital of San Agustín, Avilés, Spain.

Aisling Nic An Riogh (ANA)

Department of Urology, Cork University Hospital, Cork, Ireland.

Eabhann O'Connor (E)

Department of Urology, Beaumont Hospital, Dublin, Ireland.

Muhammad Imran Omar (MI)

University of Aberdeen, Aberdeen, UK; European Association of Urology, Arnhem, The Netherlands.

Benoit Peyronnet (B)

Department of Urology, University of Rennes, Rennes, France.

Veronique Phé (V)

Department of Urology, AP-HP, Pitié-Salpêtrière Academic Hospital, Sorbonne University, Paris, France.

Vasileios I Sakalis (VI)

Department of Urology, Agios Pavlos General Hospital of Thessaloniki, Thessaloniki, Greece.

Néha Sihra (N)

Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Lazaros Tzelves (L)

Second Department of Urology, National and Kapodistrian University of Athens, Sismanogleio General Hospital, Athens, Greece.

Mary-Lynne van Poelgeest-Pomfret (ML)

World Federation of Incontinence and Pelvic Problems, Leiden, The Netherlands.

Tine W L van den Bos (TWL)

Bekkenbodem4All, Tiel, The Netherlands.

Huub van der Vaart (H)

Department of Obstetrics and Gynecology, University Medical Center, Utrecht, The Netherlands.

Christopher K Harding (CK)

Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH